Cargando…
Atypical Subtrochanteric Femur Fracture in Patient with Metastatic Breast Cancer Treated with Zoledronic Acid
Several case series have suggested an association exists between atypical femoral subtrochanteric fractures and long-term use of bisphosphonates. It is thought that prolonged use of bisphosphonates may lead to adynamic, fragile bone. The radiologic features of atypical fractures include diffuse cort...
Autores principales: | Kim, Yong-Seok, Park, Woo-Chan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Breast Cancer Society
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3395755/ https://www.ncbi.nlm.nih.gov/pubmed/22807949 http://dx.doi.org/10.4048/jbc.2012.15.2.261 |
Ejemplares similares
-
Bisphosphonates and atypical subtrochanteric fractures of the femur
por: Kharwadkar, N., et al.
Publicado: (2017) -
SUBTROCHANTERIC FRACTURE IN A PATIENT RECEIVING ZOLEDRONIC ACID THERAPY FOR METASTATIC BREAST CANCER
por: KISHIMOTO, YASUZUMI, et al.
Publicado: (2011) -
Weekly Teriparatide for Delayed Unions of Atypical Subtrochanteric Femur Fractures
por: Fukuda, Fumio, et al.
Publicado: (2014) -
Subtrochanteric fractures of the femur: update
por: Barbosa de Toledo Lourenço, Paulo Roberto, et al.
Publicado: (2016) -
Bisphosphonates-induced Atypical Subtrochanteric Fracture Femur: A Case Report
por: Yadav, Siddhart, et al.
Publicado: (2018)